Skip to main content

Table 4 Prevalence of vomiting and nausea after acute gluten exposure in treated celiac disease patients

From: Prevalence of vomiting and nausea and associated factors after chronic and acute gluten exposure in celiac disease

Country, year

Patients

Females

Current age, yr

Duration of GFD, yr

Vomiting

Nausea

 

n

%

Mean ± SD or Median (Q1, Q3 or range)

Mean ± SD or Median (Q1, Q3 or range)

%

%

Gluten challenge: 10–14 g per day in bread or porridge for 3 days

Current study

74

75

54 (39,63)

7 (3,14)

7

12

 Spain, 2018 [33]

15

60

28 ± 4

4 ± 2

ND

13

Gluten challenge: 6 g of single gluten bolus

 Multicentera, 2020 [9]

295

69

43 ± 15

6 (3,10)b

21

61

 Australia, 2020 [12]

36

69

42 (34,54)

5 (2,8)b

44

61

 Australia, 2019 [13]

25

88

39 ± 16

4 (1–20)

24

40

Gluten challenge: 3 g gluten in single suspension

 USA, 2022 [34]

20

75

49 (37, 56)

7 (6, 11)

ND

30

Gluten challenge: 2–3 g per day in biscuit or bread for 6 weeks

 USA, 2022 [35]c

22

67

45

ND

8

21

 Finland, 2021 [36]

38

74

43 ± 14

ND

21

18

 USA, 2013 [37]

43

66

50 ± 10

6 ± 5

ND

19

 Finland, 2014 [38]

21

81

50 (19–71)

12 (1–39)

14

19

  1. GFD Gluten-free diet, ND No data
  2. aUSA, Australia and New Zealand
  3. bYears from celiac disease diagnosis
  4. cNo data about the exact form of gluten